We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
3 Sales Growth Stocks to Bet on for Robust Returns in 2026
Read MoreHide Full Article
Key Takeaways
Sales growth is pitched as a clearer demand signal than earnings, which can be distorted.
Universal Health Services is expected to post 5.2% sales growth in 2026 on its hospital network.
MEOH's 2026 sales are seen rising 9.8%, with PNW forecast at 4.6% from Arizona electricity services.
February has just started, and if you haven’t yet taken stock of your portfolio and made targeted adjustments aimed at improving risk-adjusted returns, now is the time. Several forces that defined 2025 continue to steer markets — sustained optimism around AI, the Federal Reserve’s policy path and persistent geopolitical and tariff-related uncertainties. With signals often conflicting and headlines driving short-term swings, retail investors can benefit most from a disciplined approach — reassessing allocations, tightening risk controls and ensuring the portfolio remains aligned with long-term goals.
Hence, the traditional method of choosing stocks is a good idea. Sales growth provides a more reliable view for evaluating stocks compared with earnings-focused metrics. Stocks like Universal Health Services, Inc. (UHS - Free Report) , Pinnacle West Capital Corporation (PNW - Free Report) and Methanex Corporation (MEOH - Free Report) are worth considering.
Sales growth is one of the clearest indicators of a company’s underlying momentum. Unlike earnings, which can be influenced by accounting choices or short-term cost cuts, revenue reflects real demand for a firm’s products and services. Consistent top-line expansion often points to gaining market share, a growing customer base, or successful entry into new markets. Strong revenue trends can also offer an early read on future earnings potential, as higher volumes improve operating leverage and support sustained long-term value creation.
Still, sales figures matter most in context. Benchmarking growth against peers, industry cycles and the broader economic backdrop helps distinguish durable strength from a temporary lift. Companies that can grow through different conditions tend to generate more dependable cash flows, giving management room to reinvest, fund strategic initiatives and protect balance sheet quality without overrelying on debt. Tracking these patterns can help investors spot businesses with resilient competitive advantages and a longer runway for expansion.
Selecting the Potential Winning Stocks
To shortlist stocks with impressive sales growth and a high cash balance, we have selected 5-Year Historical Sales Growth (%) greater than X-Industry and Cash Flow of more than $500 million as our main screening parameters.
But sales growth and cash strength are not the absolute criteria for selecting stocks. Hence, we have added other factors to arrive at a winning strategy.
P/S Ratio less than X-Industry: This metric determines the value placed on each dollar of a company’s revenues. The lower the ratio, the better it is for picking a stock since the investor is paying less for each unit of sales.
% Change F1 Sales Estimate Revisions (four weeks) greater than X-Industry: Estimate revisions, better than the industry, are often seen to trigger an increase in stock price.
Operating Margin (average last five years) greater than 5%: Operating margin measures how much every dollar of a company's sales translates into profits. A high ratio indicates that the company has good cost control and sales are increasing faster than costs — an optimal situation.
Return on Equity (ROE) greater than 5%: This metric will ensure that sales growth is translated into profits and the company is not hoarding cash. A high ROE means that the company is spending wisely and is, in all likelihood, profitable.
King of Prussia, PA-based Universal Health Services owns and operates acute care hospitals, behavioral health centers, surgical hospitals, ambulatory surgery centers and radiation oncology centers. UHS’ range of services includes general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care, pediatric services, pharmacy services and/or behavioral health services.
Universal Health Services’ expected sales growth rate for 2026 is 5.2%. UHS carries a Zacks Rank #2 at present.
Headquartered in Phoenix, AZ, Pinnacle West Capital provides electricity services (wholesale or retail) in the state of Arizona through its subsidiaries. PNW is involved in the generation, transmission and distribution of electricity from coal, nuclear, gas, oil and solar.
Pinnacle West Capital’s expected sales growth rate for 2026 is 4.6%. PNW currently carries a Zacks Rank #2.
Based in Vancouver, Canada, Methanex is the world’s largest supplier of methanol to North America, Asia-Pacific, Europe and Latin America. MEOH purchases methanol from others under contract and on the spot market to meet customer requirements.
MEOH’s sales are expected to rise 9.8% in 2026. Methanex carries a Zacks Rank #2 at present.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
3 Sales Growth Stocks to Bet on for Robust Returns in 2026
Key Takeaways
February has just started, and if you haven’t yet taken stock of your portfolio and made targeted adjustments aimed at improving risk-adjusted returns, now is the time. Several forces that defined 2025 continue to steer markets — sustained optimism around AI, the Federal Reserve’s policy path and persistent geopolitical and tariff-related uncertainties. With signals often conflicting and headlines driving short-term swings, retail investors can benefit most from a disciplined approach — reassessing allocations, tightening risk controls and ensuring the portfolio remains aligned with long-term goals.
Hence, the traditional method of choosing stocks is a good idea. Sales growth provides a more reliable view for evaluating stocks compared with earnings-focused metrics. Stocks like Universal Health Services, Inc. (UHS - Free Report) , Pinnacle West Capital Corporation (PNW - Free Report) and Methanex Corporation (MEOH - Free Report) are worth considering.
Sales growth is one of the clearest indicators of a company’s underlying momentum. Unlike earnings, which can be influenced by accounting choices or short-term cost cuts, revenue reflects real demand for a firm’s products and services. Consistent top-line expansion often points to gaining market share, a growing customer base, or successful entry into new markets. Strong revenue trends can also offer an early read on future earnings potential, as higher volumes improve operating leverage and support sustained long-term value creation.
Still, sales figures matter most in context. Benchmarking growth against peers, industry cycles and the broader economic backdrop helps distinguish durable strength from a temporary lift. Companies that can grow through different conditions tend to generate more dependable cash flows, giving management room to reinvest, fund strategic initiatives and protect balance sheet quality without overrelying on debt. Tracking these patterns can help investors spot businesses with resilient competitive advantages and a longer runway for expansion.
Selecting the Potential Winning Stocks
To shortlist stocks with impressive sales growth and a high cash balance, we have selected 5-Year Historical Sales Growth (%) greater than X-Industry and Cash Flow of more than $500 million as our main screening parameters.
But sales growth and cash strength are not the absolute criteria for selecting stocks. Hence, we have added other factors to arrive at a winning strategy.
P/S Ratio less than X-Industry: This metric determines the value placed on each dollar of a company’s revenues. The lower the ratio, the better it is for picking a stock since the investor is paying less for each unit of sales.
% Change F1 Sales Estimate Revisions (four weeks) greater than X-Industry: Estimate revisions, better than the industry, are often seen to trigger an increase in stock price.
Operating Margin (average last five years) greater than 5%: Operating margin measures how much every dollar of a company's sales translates into profits. A high ratio indicates that the company has good cost control and sales are increasing faster than costs — an optimal situation.
Return on Equity (ROE) greater than 5%: This metric will ensure that sales growth is translated into profits and the company is not hoarding cash. A high ROE means that the company is spending wisely and is, in all likelihood, profitable.
Zacks Rank less than or equal to 2: Zacks Rank #1 (Strong Buy) or 2 (Buy) stocks are known to outperform, irrespective of the market environment. You can see the complete list of today’s Zacks #1 Rank stocks here.
3 Stocks With Robust Sales Growth to Buy
King of Prussia, PA-based Universal Health Services owns and operates acute care hospitals, behavioral health centers, surgical hospitals, ambulatory surgery centers and radiation oncology centers. UHS’ range of services includes general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care, pediatric services, pharmacy services and/or behavioral health services.
Universal Health Services’ expected sales growth rate for 2026 is 5.2%. UHS carries a Zacks Rank #2 at present.
Headquartered in Phoenix, AZ, Pinnacle West Capital provides electricity services (wholesale or retail) in the state of Arizona through its subsidiaries. PNW is involved in the generation, transmission and distribution of electricity from coal, nuclear, gas, oil and solar.
Pinnacle West Capital’s expected sales growth rate for 2026 is 4.6%. PNW currently carries a Zacks Rank #2.
Based in Vancouver, Canada, Methanex is the world’s largest supplier of methanol to North America, Asia-Pacific, Europe and Latin America. MEOH purchases methanol from others under contract and on the spot market to meet customer requirements.
MEOH’s sales are expected to rise 9.8% in 2026. Methanex carries a Zacks Rank #2 at present.